2B, MG induced cell apoptosis (0.06% early apoptosis, 2.79% late apoptosis), and pretreatment of GLP-1 rescued MG-induced cell apoptosis (0% early apoptosis, 0.82% late apoptosis)
Monitoring is Key When using GLP-1 agonists, peptides, weight-loss protocols, or hormone therapies, consistent lab work, hormone panels, and metabolic tracking are essential
Activating two different pathways has proved to be a winning strategy
430,431 In a phase II clinical trial involving 286 ASCVD patients with elevated Lp(a) levels, 432 98% of patients receiving high-dose pelacarsen achieved the Lp(a) levels recommended by the European 433 and North American 434 guidelines
Consequently, whilst it is clearly a key component in the diet and there may be potential for supplementation to have beneficial effects, evidence to support the administration of tryptophan above and beyond what can be consumed in a healthy diet is currently lacking and further investigation is required
Reason 3: Injection anxiety outweighs benefit
